SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Carlo Palazzi, Emilio D’Amico, Salvatore D’Angelo, Michele Gilio, Pietro Leccese, Ignazio Olivieri, An update on the management of hepatitis C virus-related arthritis, Expert Opinion on Pharmacotherapy, 2014, 1

    CrossRef

  2. 2
    M. Bredemeier, Is an extra dose of rituximab an efficacious and safe alternative to improve outcomes in rheumatoid arthritis? Comment on the article by Vital et al, Annals of the Rheumatic Diseases, 2014, 73, 6, e33

    CrossRef

  3. 3
    E. M. Vital, S. Dass, M. H. Buch, A. C. Rawstron, P. Emery, Response to Dr Bredemeier's letter, Annals of the Rheumatic Diseases, 2014, 73, 6, e34

    CrossRef

  4. 4
    E. Feist, Rituximab, Zeitschrift für Rheumatologie, 2014,

    CrossRef

  5. 5
    Ana Luisa Calich, Xavier Puéchal, Grégory Pugnet, Jonathan London, Benjamin Terrier, Pierre Charles, Luc Mouthon, Loïc Guillevin, Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients, Journal of Autoimmunity, 2014, 50, 135

    CrossRef